background image

Paid Clinical Trials Green Bay

Discover 135 paid clinical trials in Green Bay, Wisconsin. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Remibrutinib vs. Teriflunomide

Recruiting
PHASE3

Sponsor:

Novartis Pharmaceuticals

Location:

Green Bay WI, Milwaukee WI, Merrillville IN, Owosso MIshow 59 more

Code:

NCT05156281

Conditions

Relapsing Multiple Sclerosis

Eligibility Criteria

Sex: All

Age: 18 - 55

Healthy Volunteers: Not accepted

Interventions

Remibrutinib

Teriflunomide

Chemotherapy with Endocrine Therapy

Recruiting
PHASE3

Sponsor:

NRG Oncology

Location:

Green Bay WI, Oconto Falls WI, Appleton WI, Neenah WIshow 715 more

Code:

NCT05879926

Conditions

Breast Cancer

Eligibility Criteria

Sex: Female

Age: 18 - 60

Healthy Volunteers: Not accepted

Interventions

Ovarian Function Suppression + Aromatase Inhibitor

Adjuvant Chemotherapy + Ovarian Function Suppression

Lenalidomide & Daratumumab

Recruiting
PHASE3

Sponsor:

SWOG Cancer Research Network

Location:

Green Bay WI, Oconto Falls WI, Appleton WI, Two Rivers WIshow 530 more

Code:

NCT04071457

Conditions

Multiple Myeloma

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Lenalidomide

Daratumumab/rHuPH20

Camizestrant

Recruiting
PHASE3

Sponsor:

AstraZeneca

Location:

Appleton WI, Milwaukee WI, Madison WI, Park Ridge ILshow 143 more

Code:

NCT05952557

Conditions

Breast Cancer, Early Breast Cancer

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Camizestrant

Tamoxifen

Anastrozole

Letrozole

Exemestane

Nivolumab, Ipilimumab, Cabozantinib

Recruiting
PHASE2

Sponsor:

National Cancer Institute (NCI)

Location:

Green Bay WI, Two Rivers WI, Oshkosh WI, Marinette WIshow 368 more

Code:

NCT03866382

Conditions

Bladder Adenocarcinoma

Bladder Clear Cell Adenocarcinoma

Bladder Mixed Adenocarcinoma

Bladder Neuroendocrine Carcinoma

Bladder Small Cell Neuroendocrine Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Bone Scan

Cabozantinib S-malate

Computed Tomography

Echocardiography Test

Observational Study

Recruiting

Sponsor:

University of Rochester NCORP Research Base

Location:

Green Bay WI, Milwaukee WI, Grand Rapids MI, Urbana ILshow 1 more

Code:

NCT06073431

Conditions

Cancer Cachexia (CC)

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Intra-operative Radiotherapy & External Beam Radiotherapy

Recruiting

Sponsor:

University College, London

Location:

Green Bay WI, Saint Joseph MI, Detroit MI, Cleveland OHshow 4 more

Code:

NCT01792726

Conditions

Early Breast Cancer

Eligibility Criteria

Sex: Female

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

Boost to the tumour bed

Paclitaxel & Ipatasertib

Recruiting
PHASE2

Sponsor:

National Cancer Institute (NCI)

Location:

Green Bay WI, Two Rivers WI, Oshkosh WI, Marinette WIshow 165 more

Code:

NCT05554380

Conditions

Locally Advanced Malignant Solid Neoplasm

Metastatic Malignant Solid Neoplasm

Unresectable Malignant Solid Neoplasm

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biopsy Procedure

Biospecimen Collection

Computed Tomography

Ipatasertib

Magnetic Resonance Imaging

Remibrutinib vs. Teriflunomide

Recruiting
PHASE3

Sponsor:

Novartis Pharmaceuticals

Location:

Neenah WI, Madison WI, Park Ridge IL, Chicago ILshow 62 more

Code:

NCT05147220

Conditions

Relapsing Multiple Sclerosis

Eligibility Criteria

Sex: All

Age: 18 - 55

Healthy Volunteers: Not accepted

Interventions

Remibrutinib

Teriflunomide

Combination Chemotherapy

Recruiting
PHASE3

Sponsor:

University of Leicester

Location:

Green Bay WI, Milwaukee WI, Marshfield WI, Grand Rapids MIshow 88 more

Code:

NCT00020566

Conditions

Sarcoma

Eligibility Criteria

Sex: All

Age: 0 - 49

Healthy Volunteers: Not accepted

Interventions

dactinomycin

busulfan

doxorubicin hydrochloride

etoposide

ifosfamide